DBV Technologies S.A.
- DBVT
- NASDAQ
- Biotechnology
- Epicutaneous Immunotherapy
- Peanut Allergy Treatment
$9.05
Today −0.66%Quote Oct 16, 2026, 08:00 PM UTC
−27.66%over the last month
Max drawdown −29.8%From 1-month high −28.3%3 months −37.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$2.68B
Quote Oct 16
Next earnings
Oct 28
Expected, not confirmed
Analyst target
$46.33
+411.9% from here
Floor
$8.52
5.9% below price
Where the price sits
15 analysts
Analyst range, low to high
$40.00$51.00
- Price $9.05
- Resistance $9.19
- Consensus $46.33
The price is right under resistance. Analysts' average target sits about 412% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DBVTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
161